WuXi Biologics (Cayman) (WuXi Biologics (Cayman)) Forward PE Ratio : 11.75 (As of Apr. 27, 2024)

View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Forward PE Ratio?

WuXi Biologics (Cayman)'s Forward PE Ratio for today is 11.75.

WuXi Biologics (Cayman)'s PE Ratio without NRI for today is 13.28.

WuXi Biologics (Cayman)'s PE Ratio for today is 15.63.

WuXi Biologics (Cayman) Forward PE Ratio Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Forward PE Ratio Chart

WuXi Biologics (Cayman) Annual Data

Trend

2018-12

2019-12

2020-12

2021-12

2022-12

2023-12

2024-04

Forward PE Ratio

54.64

82.64

181.82

63.29

30.58

21.60

11.75

WuXi Biologics (Cayman) Semi-Annual Data
	2018-03	2018-06	2018-09	2018-12	2019-03	2019-06	2019-09	2019-12	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06	2021-09	2021-12	2022-03	2022-06	2022-09	2022-12	2023-03	2023-06	2023-09	2023-12	2024-03
Forward PE Ratio	126.58	144.93	84.75	54.64	71.94	68.03	54.64	82.64	69.93	153.85	116.28	181.82	156.25	222.22	102.04	63.29	50.00	63.69	25.71	30.58	30.12	24.51	24.33	21.60	12.25

Competitive Comparison of WuXi Biologics (Cayman)'s Forward PE Ratio

For the Biotechnology subindustry, WuXi Biologics (Cayman)'s Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi Biologics (Cayman)'s Forward PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WuXi Biologics (Cayman)'s Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where WuXi Biologics (Cayman)'s Forward PE Ratio falls into.

WuXi Biologics (Cayman) Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

WuXi Biologics (Cayman) (OTCPK:WXXWY) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

WuXi Biologics (Cayman) Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi Biologics (Cayman) (WuXi Biologics (Cayman)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (OTCPK:WXXWY) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

WXIBF:USA 2269:Mexico 02269:Hong Kong 1FW1:Germany 1FW2:Germany

Address

No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092

Website

https://www.wuxibiologics.com

WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.